Event Introduces Chicago Magazine's Most Eligible Singles and Benefits Innovative Bone Marrow Transplant Research

Northwestern Medicine
News May 27, 2014
Attendees gather at the Summer Lovin Benefit Chicago magazine and The Auxiliary Board of Northwestern Memorial Hospital will introduce the magazine’s most eligible singles from their July 2014 issue at the 14th annual Summer Lovin’ fundraiser. The event will be held on Friday, June 20, 2014 at the Chicago History Museum, 1601 North Clark Street, from 7 to 10:30 p.m. 

Typically attended by more than 1,000 young professionals, Summer Lovin’ will be an evening filled with delicious food from leading Chicago restaurants, cocktails, and outstanding entertainment, as well as access to the museum’s extensive exhibits. Proceeds from the event will support innovative bone marrow transplant research to improve cancer care at Northwestern Memorial.

“The Auxiliary Board plays a unique role on the Northwestern Memorial campus, as a key sponsor of physicians who focus on diverse, groundbreaking research designed to address contemporary medical issues,” said Mindy Kurlansky, Auxiliary Board president. “This is an exciting time of year for the Board, as we are starting our second year promoting Dr. John Galvin’s innovative bone marrow transplant research at Northwestern Memorial and planning Summer Lovin’ with our incredibly supportive partner, Chicago magazine, and generous sponsors.  In an effort to maintain the level of excitement surrounding the event, the location of Summer Lovin’ has moved to the Chicago History Museum.”

Summer Lovin’ will benefit an innovative research study in bone marrow transplant led by John Galvin, MD,
Northwestern Medicine® hematologist/oncologist and member of the Robert H. Lurie Comprehensive Cancer Center at Northwestern University. Bone marrow transplant, also called hematopoietic stem cell transplant (HSCT), is the only chance for a cure in many types of blood cancers. However, success is limited by a common and sometimes fatal complication in which the donor cells begin to attack the host. This complication is called graft-versus-host disease (GVHD). The current method used to prevent GVHD is long-term immunosuppressive therapy, which carries an additional risk of infection for the patient.

“The standard approach to treating GVHD is to inhibit the patient’s immune system with immunosuppressive drugs, unfortunately these drugs also increase the risk for serious infections,” said Galvin, who is also an instructor in medicine-hematology/oncology and microbiology-immunology at Northwestern University Feinberg School of Medicine. “Therefore, we are investigating a new method to block GVHD by targeting the offending immune cells by inducing specific tolerance. If this novel approach proves successful, it could result in a safer stem cell transplant, making this important treatment accessible to a greater number of patients with blood cancers.”

In partnership with the Lurie Cancer Center, Northwestern Medicine provides state-of-the art patient care. The Lurie Cancer Center is one of only 41 National Cancer Institute (NCI)* designated “comprehensive” cancer centers in the nation. In addition, the Lurie Cancer Center is a founding member of the National Comprehensive Cancer Network (NCCN)*, an alliance of 25 of the world's leading cancer centers dedicated to improving the quality, effectiveness and efficiency of cancer care so that patients can lead better lives. 

Summer Lovin’ tickets are $95 until midnight on Saturday, May 31, then $105 through the event. VIP tickets, which include transportation and front-of-line access to the after-party at Vertigo Sky Lounge (located in the Dana Hotel), cover, and a complimentary cocktail, are an additional $20. Attire for the event is casual chic. Purchase tickets here or contact Kristyn Eskridge at Northwestern Memorial Foundation at 312-926-7133.

For more information on Northwestern Medicine cancer care, visit the Lurie Cancer Center website.
Check out these NM Care Areas:
Legal Information
*

By clicking on these websites, you are leaving the Northwestern Medicine website. These websites are independent resources. Northwestern Medicine does not operate or control the content of these websites. By visiting these websites, you agree to this third party’s terms of use for their website.